Mendus draws under the second tranche of the Fenja Capital II A/S loan facility, extending cash runway into the second quarter of 2027

What we doOur approachPipelineTechnology
About usManagementBoardClinical Advisory BoardCareers
NewsroomPress ReleasesEventsPatient Stories
Investors

Back
Mendus draws under the second tranche of the Fenja Capital II A/S loan facility, extending cash runway into the second quarter of 2027
 8:00:00 AM

Keep reading
Mendus announces initiation of the DIVA trialRead